The anti‐mitotic agents PTC‐028 and PTC596 display potent activity in pre‐clinical models of multiple myeloma but challenge the role of BMI‐1 as an essential tumour gene.

Published in:

British Journal of Haematology, 2020, v. 190, n. 6, p. 877, doi. 10.1111/bjh.16595

By:

• Bolomsky, Arnold;
• Muller, Joséphine;
• Stangelberger, Kathrin;
• Lejeune, Margaux;
• Duray, Elodie;
• Breid, Helene;
• Vrancken, Louise;
• Pfeiffer, Christina;
• Hübl, Wolfgang;
• Willheim, Martin;
• Weetall, Marla;
• Branstrom, Art;
• Zojer, Niklas;
• Caers, Jo;
• Ludwig, Heinz

Publication type:

Article